Company intelligence / Profile preview

ZentriForce Pharma

Heidelberg, Baden-Württemberg, Germanyzentriforce.com ↗

Ownership: Private
Development stage: Commercial

Overview

ZentriForce Pharma provides advanced analytical services for gene therapy products and biosimilarity studies. The company specializes in hydrodynamic techniques and has expertise in the characterization of complex biopharmaceuticals including gene therapies and peptide/protein drugs. It operates under a robust quality system aligned with WHO guidelines.

Modalities: Gene therapy product analysis (including DNA/RNA complexes, liposome-based carriers, adeno-associated viruses)Protein/peptide-based product analysis (including antibodies and peptides)Small molecule analytical services (implied by biosimilarity studies)Peptides
Industry: Drug Discovery Services

Beyond the preview

Go deeper on ZentriForce Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZentriForce Pharma.

Explore the full profile